Health
Apr 21, 2026
US cocaine use falls to 1.5% as Gen Z pivots to ketamine and psychedelics
Recent surveys show US adult cocaine use has dropped to 1.5% (4.3 million people) in 2024, with sha…
New data from the National Survey on Drug Use and Health reveal that cocaine, once a hallmark of American party culture, is losing its grip: prevalence fell to 1.5% (about 4.3 million adults) in 2024, down from 5.9 million in 2017, and use among 18‑25‑year‑olds dropped from 2.1 million to 811 000.Key DevelopmentsOverall adult cocaine use: 1.5% in 2024 vs 6.7% in early 2000s.Gen Z (18‑25) consumption fell >60% between 2017 and 2024.Purity of seized cocaine rose to 88% in 2024, up from 54% in 2020.Overdose deaths involving cocaine climbed from 10,475 in 2016 to 22,174 in 2024.Alternative substances – ketamine, psychedelics, GHB, 3‑MMC and prescription stimulants – are reported as increasingly popular in club scenes.Data & Market Impact4.3 million adults reported cocaine use in the past year (2024).Supply surge from Colombia has driven purity up, potentially intensifying health risks.Mixed‑drug environment: law‑enforcement seizures now show higher rates of cocaine combined with fentanyl or other opioids, though true contamination remains low.Why This MattersThe decline reshapes several arenas:Public health: fewer users may reduce long‑term cardiovascular disease burden, but rising overdose deaths signal a dangerous shift toward polydrug use.Law‑enforcement: reduced demand could alter trafficking routes, while higher purity may incentivize dealers to diversify into more profitable synthetics.Pharmaceutical and wellness markets: growing preference for “controlled” substances like Adderall or therapeutic ketamine points to a broader wellness‑oriented drug culture.Policy: data may prompt a re‑evaluation of the “war on drugs” narrative and encourage harm‑reduction strategies targeting mixed‑drug use.Expert InsightAnalysts attribute the shift to a convergence of cultural and economic forces. Gen Z’s heightened health consciousness and aversion to the “brash” image of cocaine drive demand toward substances perceived as safer or more therapeutic, such as ketamine, which is marketed for its antidepressant properties. At the same time, the fear of fentanyl contamination—whether statistically rare or not—creates a risk‑averse environment. Supply‑side dynamics, including record‑high Colombian output and a jump in cocaine purity to 88%, make the drug more potent, raising the stakes for accidental overdose when combined with opioids. The result is a fragmented market where cocaine is no longer the sole “star” but one component of a broader, messier drug ecosystem.What Happens NextContinued decline in pure‑cocaine use, especially among younger cohorts, is likely as alternative psych‑delics gain cultural cachet.Regulators may increase monitoring of ketamine and novel stimulants, potentially introducing new scheduling or prescription‑only frameworks.Overdose prevention efforts will need to address mixed‑drug toxicity, emphasizing testing kits and education about fentanyl‑laced supplies.Drug‑trafficking organizations could pivot toward higher‑margin synthetics, reshaping the illicit market’s geography and profit structures.
#Cocaine
#Ketamine
#Gen Z
Read More